SNHG3 and central nervous system cancer: Fei et al. reported that in glioma SNHG3 overexpression could promote the cells proliferation, inhibit apoptosis rates, and accelerate the cell cycle progress by recruiting enhancer of zeste homolog 2 to the promoter of KLF2 and p21 [26].